Yu-Hsiang Lee | Nanotechnology | Best Researcher Award

Posted on by Forensic Scientist

Prof. Yu-Hsiang Lee | Nanotechnology | Best Researcher Award

Distinguished Professor | Dept. Biomedical Sciences and Engineering/National Central University | Taiwan

Dr. Yu-Hsiang Lee is a distinguished professor in the Department of Biomedical Sciences & Engineering at National Central University (NCU), Taiwan. He is renowned for his research in nanomedicine, hydrogel-based biomaterials, and mechanotransductional biology. He holds a Ph.D. in Chemical Engineering from the University of Southern California and has accumulated significant experience in academic and industry roles. His contributions to the field of biomedical engineering have positioned him as a key figure in advancing therapies for cancer and chronic wound healing.

Profile

Google Scholar

Orcid

Scopus

Strengths for the Awards

  • Expertise and Experience: Dr. Lee holds a distinguished academic and professional career in biomedical engineering and chemical engineering. His position as a Distinguished Professor and leadership roles such as Associate Dean further demonstrate his excellence in academia.
  • Innovative Research: His work on PFC nanopolymersomes and exosomes for cancer therapy is groundbreaking, especially in addressing challenges like hypoxia in cancer treatment. His research in nanomedicine, drug delivery, and biomaterials is highly innovative and practical.
  • Strong Publication Record: With 40 journals published and a significant citation index (879 citations), Dr. Lee’s research has had a meaningful impact on his field. His work is published in high-impact journals, which highlights the quality and relevance of his contributions.
  • Industry and Collaborative Engagement: Dr. Lee’s involvement with various industry partners and hospitals demonstrates the real-world applicability and potential of his research. His collaborations with both academic and industry entities, such as Somapex Inc., YU GREEN CO., and Cathay General Hospital, reflect his commitment to advancing scientific knowledge in tandem with practical applications.
  • Ongoing Research and Innovation: Dr. Lee is engaged in ongoing research that is funded by the National Science and Technology Council in Taiwan, which indicates that his work is both cutting-edge and supported by recognized national research institutions.

Education 🎓

Dr. Lee completed his B.S. in Chemical Engineering at Tunghai University (Taiwan) in 1998, followed by an M.S. and Ph.D. in Chemical Engineering from the University of Southern California (USA) in 2002 and 2006, respectively. His academic background has laid a strong foundation for his pioneering research in biomedical engineering and nanomedicine.

Experience 💼

Dr. Lee has a diverse professional background. After earning his Ph.D., he worked as a research scientist at Sierra Sciences LLC (USA) from 2006 to 2008, focusing on drug discovery. He then joined the UCLA Dental Research Institute as a postdoctoral fellow, working on biomarker discovery projects. Since 2010, Dr. Lee has held several academic positions at NCU, including Assistant Professor, Associate Professor, Professor, and most recently, Distinguished Professor in 2022. He has also served as the Associate Dean for NCU’s College of Health Sciences & Technology from 2020 to 2023.

Research Interests On Nanotechnology 🔬

Dr. Lee’s current research interests include:

  1. Nanomedicine for cancer and bacterial infection therapies.
  2. Hydrogel-based biomaterials for chronic wound healing.
  3. Photobioreactor engineering for enhanced microalgae cultivation.
  4. Mechanotransductional biology for vascular and tumor microenvironment studies.
    His interdisciplinary research merges advanced materials science with biomedical engineering to develop innovative solutions for pressing health challenges.

Award 🏆

Dr. Lee’s groundbreaking research has earned him recognition and multiple awards. He is currently nominated for the Best Researcher Award at the Forensic Scientist Awards. His innovations, particularly in the development of perfluorocarbon (PFC) nanopolymersomes, have established him as a leader in nanomedicine. These nanocarriers are particularly promising for cancer therapy, providing effective oxygen delivery and drug loading for combined therapies.

Publication 📚

  • Novel silver and nanoparticle-encapsulated growth factor co-loaded chitosan composite hydrogel with sustained antimicrobility and promoted biological properties for diabetic …
    • Authors: YH Lee, YL Hong, TL Wu
    • Year: 2021
    • Citations: 84
  • Fabrication, characterization, and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted …
    • Authors: YH Lee, DS Chang
    • Year: 2017
    • Citations: 66
  • Synthesis and biological evaluation of quercetin–zinc (II) complex for anti-cancer and anti-metastasis of human bladder cancer cells
    • Authors: YH Lee, PT Tuyet
    • Year: 2019
    • Citations: 42
  • Chitosan/PVA hetero-composite hydrogel containing antimicrobials, perfluorocarbon nanoemulsions, and growth factor-loaded nanoparticles as a multifunctional dressing for …
    • Authors: YH Lee, SJ Lin
    • Year: 2022
    • Citations: 35
  • Synthesis, characterization, and biological verification of anti-HER2 indocyanine green–doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for …
    • Authors: YH Lee, YT Ma
    • Year: 2017
    • Citations: 32
  • Anti-EGFR indocyanine green-mitomycin C-loaded perfluorocarbon double nanoemulsion: A novel nanostructure for targeted photochemotherapy of bladder cancer cells
    • Authors: YH Lee, YC Lin
    • Year: 2018
    • Citations: 24
  • Fluid shear stress induces cell cycle arrest in human urinary bladder transitional cell carcinoma through bone morphogenetic protein receptor-smad1/5 pathway
    • Authors: YH Lee, CW Lai, YC Cheng
    • Year: 2018
    • Citations: 19
  • Synthesis, characterization, and biological evaluation of anti-her2 indocyanine green-encapsulated peg-coated plga nanoparticles for targeted phototherapy of breast cancer cells
    • Authors: YH Lee, YH Lai
    • Year: 2016
    • Citations: 17
  • Reduction of oxygen inhibition effect for microalgal growth using fluoroalkylated methoxy polyethylene glycol-stabilized perfluorocarbon nano-oxygen carriers
    • Authors: YH Lee, YL Yeh
    • Year: 2015
    • Citations: 16
  • Using fluorochemical as oxygen carrier to enhance the growth of marine microalga Nannochloropsis oculata
    • Authors: YH Lee, YL Yeh, KH Lin, YC Hsu
    • Year: 2013
    • Citations: 15

Conclusion 📝

Dr. Yu-Hsiang Lee’s career has been marked by a series of groundbreaking contributions to biomedical engineering, particularly in nanomedicine and biomaterials. His work not only addresses crucial health challenges but also paves the way for new therapeutic strategies in cancer treatment and chronic wound healing. As a distinguished professor, he continues to lead innovative research that bridges science, engineering, and medicine, making significant strides toward improving patient outcomes and advancing medical technology.

Verena Poinsot | Nanotechnology | Best Researcher Award

Posted on by Forensic Scientist

Dr. Verena Poinsot | Nanotechnology | Best Researcher Award

First class Research Director | CNRS – national center for scientific research | France

Verena Poinsot-Hauke is a distinguished researcher with a specialization in bioorganic chemistry, currently a Senior Research Director at the CNRS in Toulouse, France. Her work focuses on pioneering drug delivery systems through exosome-derived nanomaterials. Known for her interdisciplinary approach, she combines expertise across chemistry, biology, and environmental science to explore molecular interactions and signalization in medical and ecological systems.

Profile

Scopus

Strengths for the Award

  • Extensive Research and Leadership Experience: Poinsot-Hauke has held senior positions at CNRS and has been instrumental in managing diverse research teams, including her work as a Senior Researcher and Team Leader. Her expertise spans multiple areas, including bioorganic and analytical organic chemistry, molecular and supramolecular chemistry, and nanomaterials for drug delivery systems.
  • Interdisciplinary Expertise: Her work bridges multiple scientific fields, notably chemistry, biology, and environmental sciences. This ability to operate across disciplines is critical in modern research environments and shows her adaptability and breadth of knowledge.
  • Significant Research Output and Impact: With 77 peer-reviewed publications, an h-index of 27, and over 2,600 citations, Poinsot-Hauke demonstrates a robust record of scientific contributions. Her published work’s wide recognition suggests a strong impact within her field.
  • Innovative Research Contributions: She has developed pioneering work on exosome-derived nanomaterials for drug delivery and molecular dialogue studies in cardiac and cancer cells, showing her active engagement in cutting-edge, impactful research areas.
  • Notable International Collaboration and Recognition: Her role as an international expert in China and various leadership roles within French academic institutions reflect her global influence and respect in the research community.
  • Patent Contributions: With four patents (two of which are exclusively licensed), Poinsot-Hauke’s research has commercial applications, showcasing her ability to translate scientific findings into practical, marketable innovations.

Education 🎓

Verena Poinsot-Hauke’s educational background is rooted in rigorous scientific training in chemistry. She earned a PhD in Analytical Organic Chemistry from the University Louis Pasteur in Strasbourg in 1994, supported by the Ministry for Research and Technology and Elf Aquitaine. Previously, she completed her Master’s in Molecular and Supramolecular Chemistry in 1991. In 2000, she received her national accreditation to supervise research, specializing in bioorganic chemistry.

Experience 💼

Poinsot-Hauke has a prolific research career spanning various key roles. Currently, she is a Senior Research Director at CNRS UMR5085 CIRIMAT, focusing on exosome-derived nanomaterials. Her previous roles include serving as a senior researcher at UMR1048 I2MC, an international expert for Guangdong province, and a team leader in cancer immunology at UMR 5623 IMRCP. Her research journey started as a lecturer in Germany, followed by post-doctoral work in Hamburg, marking her growth into a prominent scientific figure.

Research Interests 🔬

Verena’s research centers on engineering novel drug delivery systems using exosome-derived nanomaterials and studying molecular communication in cardiac and cancer microenvironments. Her interdisciplinary approach explores the structural characterization of biomolecules, plant-microbe interactions, and environmental biomarkers. She is also engaged in pioneering studies on exosomal molecular dialogues, including macrophage and cancer cell signaling.

Awards 🏆

Verena Poinsot-Hauke has received numerous accolades for her contributions to science. She was appointed as a Vice-President of the University Paul Sabatier and has led multiple prestigious projects at CNRS and University Paul Sabatier, reflecting her dedication to research excellence, leadership, and mentorship within the scientific community.

Publications 📚

  • Title: “Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery”
    Authors: Poinsot, V., Pizzinat, N., Ong-Meang, V.
    Journal: Nanomaterials
    Year: 2024
    Citations: 4
  • Title: “Extracellular Vesicles Produced by the Cardiac Microenvironment Carry Functional Enzymes to Produce Lipid Mediators In Situ”
    Authors: Ong-Meang, V., Blanzat, M., Savchenko, L., Pizzinat, N., Poinsot, V.
    Journal: International Journal of Molecular Sciences
    Year: 2023
    Citations: 2
  • Title: “Genomic Insights and Functional Analysis Reveal Plant Growth Promotion Traits of Paenibacillus mucilaginosus G78”
    Authors: Wang, D., Poinsot, V., Li, W., Zhou, C., Gu, W.
    Journal: Genes
    Year: 2023
    Citations: 4
  • Title: “Twenty years of amino acid determination using capillary electrophoresis: A review”
    Authors: Ta, H.Y., Collin, F., Perquis, L., Ong-Meang, V., Couderc, F.
    Journal: Analytica Chimica Acta
    Year: 2021
    Citations: 59
  • Title: “Lipo-chitooligosaccharides as regulatory signals of fungal growth and development”
    Authors: Rush, T.A., Puech-Pagès, V., Bascaules, A., Bécard, G., Ané, J.-M.
    Journal: Nature Communications
    Year: 2020
    Citations: 60
  • Title: “Extracellular vesicles of MSCs and cardiomyoblasts are vehicles for lipid mediators”
    Authors: Pizzinat, N., Ong-Meang, V., Bourgailh-Tortosa, F., Parini, A., Poinsot, V.
    Journal: Biochimie
    Year: 2020
    Citations: 15
  • Title: “The ex planta signal activity of a Medicago ribosomal uL2 protein suggests a moonlighting role in controlling secondary rhizobial infection”
    Authors: Sorroche, F., Morales, V., Mouffok, S., Gough, C., Batut, J.
    Journal: PLoS ONE
    Year: 2020
    Citations: 1
  • Title: “Capillary electrophoresis/visible-LED induced fluorescence of tryptophan: What’s new?”
    Authors: Perquis, L., Ta, H.Y., Ong-Meang, V., Poinsot, V., Couderc, F.
    Journal: Electrophoresis
    Year: 2019
    Citations: 5
  • Title: “Endosymbiotic Sinorhizobium meliloti modulate Medicago root susceptibility to secondary infection via ethylene”
    Authors: Sorroche, F., Walch, M., Zou, L., Batut, J., Garnerone, A.-M.
    Journal: New Phytologist
    Year: 2019
    Citations: 8
  • Title: “IL13-mediated dectin-1 and mannose receptor overexpression promotes macrophage antitumor activities through recognition of sialylated tumor cells”
    Authors: Alaeddine, M., Prat, M., Poinsot, V., Pipy, B., Coste, A.
    Journal: Cancer Immunology Research
    Year: 2019
    Citations: 20

Conclusion 🎯

Verena Poinsot-Hauke’s career is a testament to her dedication to advancing scientific knowledge at the intersections of chemistry, biology, and medicine. Her research has contributed valuable insights into bioorganic chemistry, nanotechnology, and cellular communication, making her a leader in her field and a source of inspiration for future scientists.

Willian Becker | Nanotecnologia | Best Researcher Award

Posted on by Forensic Scientist

Dr. Willian Becker | Nanotecnologia | Best Researcher Award

Dr at Universidade Federal do Rio de Janeiro, Brazil

Dr. Willian Pinheiro Becker is a dedicated researcher and biochemist currently pursuing his Ph.D. in Biochemistry and Molecular Biology at the Federal University of Rio de Janeiro (UFRJ), under the guidance of Jasmin. He holds a Master’s degree in the same field, with extensive training in biotechnology and toxicological analyses. Dr. Becker has a strong background in cytology and cellular biology, contributing to research and development initiatives at UFRJ’s Multidisciplinary Research Center. His work focuses on the molecular mechanisms behind cell differentiation, with applications in biotechnology and nanotechnology. He has been a recipient of multiple research grants from FAPERJ and is actively involved in advancing molecular diagnostics.

Profile

ORCID

Educational

      • Ph.D. in Progress in Biochemistry and Molecular Biology, Multicenter Postgraduate Program in Biochemistry and Molecular Biology (PMBQBM), Brazil. Advisor: Jasmin.
        Grantee: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do RJ (FAPERJ), Brazil.
      • Master’s in Biochemistry and Molecular Biology (2020–2022), PMBQBM, Brazil.
        Advisor: Jasmin.
        Grantee: FAPERJ, Brazil.
      • Bachelor’s in Biomedicine (2010–2014), Universidade Católica de Petrópolis (UCP), Brazil.
        Advisor: Dr. Adriana Afonso.

Professional Experience

Dr. Becker is currently a research fellow at the Universidade Federal do Rio de Janeiro (UFRJ), where he has been involved in research and development activities at the Núcleo Multidisciplinar de Pesquisa (NUMPEX-BIO) since 2019. He has been working under an exclusive dedication contract, focusing on cellular biology, biotechnology, and toxicological assessments. His current position is funded by FAPERJ. His research primarily revolves around biochemistry and molecular biology, specifically in areas such as cell differentiation, cellular biology, and cytology. Dr. Becker has contributed to significant research projects since joining UFRJ, with ongoing collaborations in multidisciplinary teams focused on biotechnology applications and molecular diagnostics.

Research Interests

Dr. Becker’s research interests span several critical areas of biological and health sciences, including:

  • Biochemistry and Molecular Biology
  • Biotechnology and its applications in cellular differentiation and biomineralization
  • Toxicological evaluations in the pharmaceutical context
  • Cytology and cellular biology, with a focus on molecular diagnostics

Author Metrics

  • Dr. Becker’s research interests span several critical areas of biological and health sciences, including:
    • Biochemistry and Molecular Biology
    • Biotechnology and its applications in cellular differentiation and biomineralization
    • Toxicological evaluations in the pharmaceutical context
    • Cytology and cellular biology, with a focus on molecular diagnostics

Publications

Caracterização do uso de nanopartículas magnéticas-fluorescentes de óxido de ferro em células-tronco mesenquimais derivadas de tecido adiposo humano

2022-07-03 | dissertation-thesis

 

Source:Willian Pinheiro Becker